A RIPPLE EFFECT OF COVID-19 PANDEMIC ON SHORTAGE OF MEDICINAL PRODUCTS AND ITS IMPACT ON PATIENT CARE
DOI:
https://doi.org/10.22159/ijap.2021v13i5.42177Keywords:
Drug shortage, Unavailability, COVID-19, US FDA, EAHP, Medicinal product shortageAbstract
Objective: Shortages of medicinal products are complex global problems. Drug shortages remain a significant public health issue. Global shortages of medical products have a potential effect on patient health and total healthcare costs. Countries worldwide, especially those affected by Coronavirus disease 2019 (COVID-19), is experiencing a rapid increase in drug shortage, which causes several complications for physicians, health care provider, patients, health institutes and health regulatory bodies.
Methods: To carry out the study of shortages, several efforts have been taken by the regulators and industries. Prominent amongst these include FDA's research the needs and the reforms made in the regulations about shortages. We also searched for electronic databases (PubMed, Science direct, Web of Science) using the terms (COVID-19 and shortage) or (medicine and COVID-19) for articles in periods of 2019 to 2021.
Results: On assessment based on the report, the number of shortage drugs in 2020 is 835; Anesthesia drugs are highest during the COVID-19 outbreak data indicate the number of shortages is 143 in USA. It was found that generic products were mostly in short supply, with antimicrobial agents (63%) topping the list of therapeutic categories of medicines with interrupted supply, followed by oncology medicines (47%) and then anesthetic agents (38%) during COVID-19 pandemic.
Conclusion: Many steps have been taken to reduce the impact of a shortage of health care. Agencies like the United States Food and Drug Administration (US FDA) and European Medicines Agency (EMA) has established guidelines and works with manufacturers and other partners to help prevent shortages. This article aims to the analysis the root cause of medicinal product shortages, their effects on the patient outcome, medication error, which occurs due to the substitution safe and effective therapies with alternative treatments, identify possible solutions and policies established to manage medicinal product shortages.
Downloads
References
Tucker EL, Cao Y, Fox ER, Sweet BVJCP. The drug shortage era: a scoping review of the literature 2001–2019. Therapeutics 2020;108:1150-5.
Holcombe B, Mattox TW, Plogsted SJNiCP. Drug shortages: effect on parenteral nutrition therapy. Nutr Clin Pract 2018;33:53-61.
Ventola CLJP. The drug shortage crisis in the United States: causes, impact, and management strategies. Therapeutics 2011;36:740.
U. S. Food and Drug Administration. Drug shortages infographic; 2019. Available from: https://www.fda.gov/ drugs/drug-shortages/drug-shortages-infographic. [Last accessed on 20 Apr 2021].
Fox ER, Birt A, James KB, Kokko H, Salverson S, Soflin DLJAjoh-sp. ASHP guidelines on managing drug product shortages in hospitals and health systems. Am J Health Syst Pharm 2009;66:1399-406.
Phuong JM, Penm J, Chaar B, Oldfield LD, Moles RJPo. The impacts of medication shortages on patient outcomes: a scoping review. PloS One 2019;14:e0215837.
McLaughlin M, Kotis D, Thomson K, Harrison M, Fennessy G, Postelnick M, et al. Effects on patient care caused by drug shortages: a survey. J Manag Care Pharm 2013;19:783-8.
Association AH. Recent trends in hospital drug spending and manufacturer shortages; 2019. Available from: https://www.aha.org/2019-01-15-recent-trends-hospital-drug-spending-and-manufacturer-shortages. [Last accessed on 10 Feb 2021]
Sacks CA, Kesselheim AS, Fralick MJJim. The shortage of normal saline in the wake of Hurricane Maria. JAMA Intern Med 2018;178:885-6.
Vail E, Gershengorn HB, Hua M, Walkey AJ, Rubenfeld G, Wunsch HJJ. Association between US norepinephrine shortage and mortality among patients with septic shock. JAMA 2017;317:1433-42.
Donohue JM, Angus DCJJ. National shortages of generic sterile injectable drugs: norepinephrine as a case study of potential harm. JAMA 2017;317:1415-7.
Sp M, PD, Mk H. A clinical study of siddha herbal preparation–m v kashayam for the treatment, control, and management of covid-19. Asian J Pharm Clin Res 2021;14:104-7.
Dewi YA, Permana AD, Oktrivianto DA. The impact of covid-19 pandemic to head and neck cancer care in hasan sadikin hospital bandung, Indonesia. Int J Pharm Pharm Sci 2021;13:63-6.
Badreldin HA, Atallah BJRiS, Pharmacy A. Global drug shortages due to COVID-19: impact on patient care and mitigation strategies. Res Social Adm Pharm 2021;17:1946-9.
BV, Babu A, Maria F, Antony S. the potential of remdesivir against sars cov 2: a review. Int J Curr Pharm Res 2020;12:20-3.
Viswanath K, Rn H, Basra SS, Chourey N. Coronavirus disease 2019 vaccination drive: the perceptions and acceptance of vaccination among health care workers. Asian J Pharm Clin Res 2021;14:177-81.
Abedrabboh K, Pilz M, Al-Fagih Z, Al-Fagih OS, Nebel JC, Al-Fagih L. Game theory to enhance stock management of personal protective equipment (PPE) during the COVID-19 outbreak. PLOS One 2021;16:e0246110.
Abedrabboh K, Pilz M, Al-Fagih Z, Al-Fagih OS, Nebel JC, Al-Fagih LJPO. Game theory to enhance stock management of personal protective equipment (PPE) during the COVID-19 outbreak. PLoS One 2021;16:e0246110.
Ranney ML, Griffeth V, Jha AK. Critical supply shortages-the need for ventilators and personal protective equipment during the covid-19 pandemic. New England J Med 2020;382:e41.
Barrera K, McNicoll CF, Sangji NFJBotACoS. Drug shortages: the invisible epidemic. Bulletin 2018;103:24-9.
European Association of Hospital Pharmacists (EAHP). Medicines shortage survey 2019; 2020. Available from: https://www.eahp.eu/practice-and-policy/medicines-shortages/2019-medicines-shortage-survey. [Last accessed on 10 Feb 2021]
National pharmaceutical pricing authority ministry of chemicals and fertilizers goi. Pharma Jan Samadhan; 2021. Available from: https://www.nppaindia.nic.in/en/homelinks/pharma-jan-samadhan/. [Last accessed on 10 Feb 2021]
Hjacalyn M Duffin JP. Medicine shortages in light of COVID-19: a wake-up call for drug security. The Hill Times; 2020.
Drug shortages Canada. Summary Report: Bell Canada under contract with Health Canada; 2021. Available from: https://www.drugshortagescanada.ca/rws-search?perform=1. [Last accessed on 10 Feb 2021]
European Association of Hospital Pharmacists (EAHP). Medicines Shortage Survey; 2014. Available from: https://www.eahp.eu/practice-and-policy/medicines-shortages/2014-medicines-shortage-survey. [Last accessed on 10 Feb 2021]
U. S. Food and drug administration. About FDA; 2020. Available from: https://www.fda.gov/about-fda. [Last accessed on 10 Feb 2021]
European Association of Hospital Pharmacists (EAHP). Who we are; 2021. Available from: https://www.eahp.eu/about-us/who-we-are. [Last accessed on 10 Feb 2021]
ISPE. Report on the ISPE drug shortages survey; 2013. Available from: https://ispe.org/sites/default/files/initiatives/drug-shortages/2013-ISPE-drug-shortages-survey-report.pdf. [Last accessed on 10 Feb 2021]
U. S. Food and drug administration. Current and resolved drug shortages and discontinuations reported to FDA; 2021. Available from: https://www.accessdata.fda.gov/ scripts/drugshortages/. [Last accessed on 10 Feb 2021]
Medicines shortages in European Hospitals. Eur J Hospital Pharm; 2014. Available from: https://www.eahp.eu/ sites/default/files/files/shortages%20report16_09.pdf. [Last accessed on 10 Feb 2021]
Miljkovic N, Gibbons N, Batista A, Fitzpatrick RW, Underhill J, Horak P. Results of EAHP’s 2018 survey on medicines shortages. Eur J Hospital Pharm 2019;26:60.
Miller FA, Young SB, Dobrow M, Shojania KGJBQ, Safety. Vulnerability of the medical product supply chain: the wake-up call of COVID-19. BMJ 2021;30:331-5.
Food and Drug Administration DoHaHS. Report on Drug Shortages; 2017.
Gray A, Manasse Jr HR. Shortages of medicines: a complex global challenge. SciELO Public Health; 2012.
K Oanh Ha AR. Now the world’s hospitals are running out of vital rubber gloves. Bloomberg; 2020.
Reed BN, Fox ER, Konig M, Jackevicius CA, Masoudi FA, Rabinstein AA, et al. The impact of drug shortages on patients with cardiovascular disease: causes, consequences, and a call to action. Am Heart J 2016;175:130-41.
Published
How to Cite
Issue
Section
Copyright (c) 2021 BIPLAB KUMAR DEY, EFFICIENCY MYRSING, RUHUL AMIN, FARUK ALAM, MIZANUR RAHMAN, PAL GOGOI, TAHMINA AFROZ
This work is licensed under a Creative Commons Attribution 4.0 International License.
